Biotest Pharma GmbH
PolandAll drugs from this manufacturer
-
It is used to replenish and maintain circulating blood volume in situations where a decrease has been identified and the use of albumin is appropriate.
Dosage form: solution for infusion
Active substance Dosage total protein including at least 95% human albumin 200 g/l ATC: B05AA01
-
The medicinal product is used for the treatment and prevention of bleeding in individuals suffering from hemophilia A (congenital factor VIII deficiency).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor vii 100 j.m./1 ml ATC: B02BD02
-
The medicinal product is used for the treatment and prevention of bleeding in people suffering from hemophilia A (congenital factor VIII deficiency).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor vii 50 j.m./1 ml ATC: B02BD02
-
The medicinal product is used for the treatment and prevention of bleeding in individuals suffering from hemophilia A (congenital factor VIII deficiency).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor vii 500 j.m. ATC: B02BD02
-
The medicine is used to provide immediate and long-term protection against hepatitis B virus. It is used in unvaccinated or under-vaccinated individuals who are exposed to infection, in liver transplant patients (to prevent re-infection), in newborns whose mothers are infected, and in individuals for whom the vaccine was not effective.
Dosage form: solution for infusion
Active substance Dosage human hepatitis b immunoglobulin 50 j.m./ml ATC: J06BB04
-
The medicinal product is used in adults, children, and adolescents to supplement antibody deficiency (in cases of congenital or acquired immunodeficiency) and in the treatment of certain inflammatory diseases, such as immune thrombocytopenia, Guillain-Barré syndrome, Kawasaki disease, or chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy (CIDP and MMN).
Dosage form: solution for infusion
Active substance Dosage human normal immunoglobulin No input provided ATC: J06BA02
-
It is used in adults, children, and adolescents for antibody replacement therapy or in the treatment of inflammatory diseases, such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, or chronic nerve diseases.
Dosage form: solution for infusion
Active substance Dosage human normal immunoglobulin 100 g/l ATC: J06BA02
-
The medicine is administered to patients receiving immunosuppressive treatment (suppressing the immune system) to prevent symptoms of cytomegalovirus infection, especially in organ transplant recipients.
Dosage form: solution for infusion
Active substance Dosage human cytomegalovirus immunoglobulin 100 U/ml ATC: J06BB09
-
The medicine is used to treat bacterial infections (in conjunction with antibiotics) and for replacement therapy in individuals who have insufficient antibodies due to severe immune system deficiencies.
Dosage form: solution for infusion
Active substance Dosage human normal immunoglobulin for intravenous use 50 mg/ml ATC: J06BA02